Acurx Pharmaceuticals Inc’s filing revealed that its Director Scodari Joseph C acquired Company’s shares for reported $25000.0 on Jan 06 ’25. In the deal valued at $1.01 per share,24,631 shares were bought. As a result of this transaction, Scodari Joseph C now holds 27,708 shares worth roughly $16624.8.
Then, Sailer Carl bought 24,631 shares, generating $25,000 in total proceeds. Upon buying the shares at $1.01, the Director now owns 137,183 shares.
Before that, LUCI DAVID P bought 49,261 shares. Acurx Pharmaceuticals Inc shares valued at $50,000 were divested by the President and CEO at a price of $1.01 per share. As a result of the transaction, LUCI DAVID P now holds 1,097,458 shares, worth roughly $0.66 million.
Price Performance Review of ACXP
On Monday, Acurx Pharmaceuticals Inc [NASDAQ:ACXP] saw its stock jump 9.55%% to $0.6. Over the last five days, the stock has gained 97.54%. Acurx Pharmaceuticals Inc shares have fallen nearly -73.22% since the year began. Nevertheless, the stocks have fallen -25.98% over the past one year. While a 52-week high of $3.33 was reached on 01/06/25, a 52-week low of $0.30 was recorded on 06/16/25.
Levels Of Support And Resistance For ACXP Stock
The 24-hour chart illustrates a support level at 0.5371, which if violated will result in even more drops to 0.4718. On the upside, there is a resistance level at 0.6499. A further resistance level may holdings at 0.6974.
How much short interest is there in Acurx Pharmaceuticals Inc?
A steep rise in short interest was recorded in Acurx Pharmaceuticals Inc stocks on 2025-05-30, dropping by 57527.0 shares to a total of 0.3 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 0.35 million shares. There was a decline of -19.47%, which implies that there is a negative sentiment for the stock.